Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
ZYDUSLIFE
ZYDUSLIFE

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE
BSE: 532321
Sector: Healthcare
Industry: Pharmaceuticals
1,148.00-5.0 (-0.43%)
8 Jul, 12:00 AM

Stock Scores

Quality Score

83.7 / 100

Value Score

55.6 / 100

Price Momentum Score

91.8 / 100

QVM Score

95.5 / 100

Key Metrics

Market Cap
1,14,513 Cr
P/E (TTM)
22.72
P/B
4.22
P/S (TTM)
4.22
EV/EBITDA
16.62
CAPE (5Y)
32.95
ROE (TTM)
19.74
ROCE (TTM)
16.15
ROA (TTM)
11.25
Avg 3Y ROE
20.36
Earnings 3Y CAGR
37.32
Sales 3Y CAGR
16.35
Sales 5Y CAGR
12.45
Debt/Equity
0.46
Consensus TP
1121.00
Strong Buy %
20.00
Promoter Holding
75.00
Pledged %
0.00

Share Price

Track Zydus Lifesciences Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 3.50 %
Low
1,095.1
High
1,181.5
1 Month returns: 5.55 %
Low
1,053.8
High
1,181.5
1 Year returns: 16.76 %
Low
835.5
High
1,181.5
3 Year CAGR: 25.21 %
Low
567.8
High
1,324.3
5 Year CAGR: 12.75 %
Low
319.0
High
1,324.3
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Zydus Lifesciences Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Zydus Lifesciences Ltd. Shareholding Pattern

Quarterly breakdown of Zydus Lifesciences Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Zydus Lifesciences Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Zydus Lifesciences Ltd.?
The current share price of Zydus Lifesciences Ltd. is ₹ 1,148.00 as of 8 Jul 2026.
What is the market capitalisation of Zydus Lifesciences Ltd.?
The market capitalisation of Zydus Lifesciences Ltd. stands at ₹ 1,14,513.00 Cr.
What is the PE ratio of Zydus Lifesciences Ltd.?
The Price-to-Earnings (PE) ratio of Zydus Lifesciences Ltd. is 22.72 as of the latest trailing twelve months data.
What is the ROE and ROCE of Zydus Lifesciences Ltd.?
Zydus Lifesciences Ltd. has a Return on Equity (ROE) of 19.74% and a Return on Capital Employed (ROCE) of 16.15% as per the latest financial reports.
What is the 52-week high and low of Zydus Lifesciences Ltd.?
The 52-week high of Zydus Lifesciences Ltd. is - and the 52-week low is -.
What is the dividend yield of Zydus Lifesciences Ltd.?
The dividend yield of Zydus Lifesciences Ltd. is 0.96% based on the current market price.
What is the FII and DII holding in Zydus Lifesciences Ltd.?
Foreign Institutional Investors (FII) hold 6.95%, Domestic Institutional Investors (DII) hold 11.02% and retail/public investors hold 6.30% of Zydus Lifesciences Ltd. shares.
What sector does Zydus Lifesciences Ltd. belong to?
Zydus Lifesciences Ltd. operates in the Healthcare sector. 50% of analysts have a Buy or Strong Buy rating on Zydus Lifesciences Ltd. with a consensus target price of ₹ 1,121.00, implying 2.35% downside from current levels.
What is the beta of Zydus Lifesciences Ltd.?
The beta of Zydus Lifesciences Ltd. is 0.74, indicating its price volatility relative to the broader market. Over the past 1 year, Zydus Lifesciences Ltd. has delivered an absolute return of 15.97%.
What is the RSI of Zydus Lifesciences Ltd.?
The 14-day Relative Strength Index (RSI) of Zydus Lifesciences Ltd. is 67.09, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.